These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3290485)

  • 1. Conformationally constrained renin inhibitory peptides: gamma-lactam-bridged dipeptide isostere as conformational restriction.
    Thaisrivongs S; Pals DT; Turner SR; Kroll LT
    J Med Chem; 1988 Jul; 31(7):1369-76. PubMed ID: 3290485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin inhibitors based on dipeptide analogues. Incorporation of the hydroxyethylene isostere at the P2/P3 sites.
    Kempf DJ; de Lara E; Stein HH; Cohen J; Egan DA; Plattner JJ
    J Med Chem; 1990 Jan; 33(1):371-4. PubMed ID: 2404121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
    Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
    J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
    Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
    J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
    Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
    J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.
    Thaisrivongs S; Blinn JR; Pals DT; Turner SR
    J Med Chem; 1991 Apr; 34(4):1276-82. PubMed ID: 2016704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin inhibitory peptides: a study of structural modifications in the peptide backbone.
    Thaisrivongs S; Pals DT; Turner SR; Kroll LT
    J Hypertens Suppl; 1989 Apr; 7(2):S21-3. PubMed ID: 2666608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin inhibitors containing isosteric replacements of the amide bond connecting the P3 and P2 sites.
    Kaltenbronn JS; Hudspeth JP; Lunney EA; Michniewicz BM; Nicolaides ED; Repine JT; RoarK WH; Stier MA; Tinney FJ; Woo PK
    J Med Chem; 1990 Feb; 33(2):838-45. PubMed ID: 2405159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
    Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
    J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of Freidinger lactams and their analogs in the design of conformationally constrained peptidomimetics.
    Perdih A; Kikelj D
    Curr Med Chem; 2006; 13(13):1525-56. PubMed ID: 16787202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide renin inhibitors employing a novel 3-aza(or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement.
    Baker WR; Fung AK; Kleinert HD; Stein HH; Plattner JJ; Armiger YL; Condon SL; Cohen J; Egan DA; Barlow JL
    J Med Chem; 1992 May; 35(10):1722-34. PubMed ID: 1588554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and biological activities of renin inhibitors containing statine analogues.
    Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homoserine-derived cyclic sulfamidate as chiral educt for the diversity-oriented synthesis of lactam-bridged dipeptides.
    Galaud F; Lubell WD
    Biopolymers; 2005; 80(5):665-74. PubMed ID: 15791637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors.
    de Laszlo SE; Bush BL; Doyle JJ; Greenlee WJ; Hangauer DG; Halgren TA; Lynch RJ; Schorn TW; Siegl PK
    J Med Chem; 1992 Mar; 35(5):833-46. PubMed ID: 1548675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
    Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aminopeptidases by peptides containing ketomethylene and hydroxyethylene amide bond replacements.
    Harbeson SL; Rich DH
    J Med Chem; 1989 Jun; 32(6):1378-92. PubMed ID: 2566685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.